HEMISPHERE ENERGY CORP (HME.CA) Stock Fundamental Analysis
TSX-V:HME • CA4236301020
2.12 CAD
-0.05 (-2.3%)
Last: Feb 12, 2026, 07:00 PM
Overall HME gets a fundamental rating of 7 out of 10. We evaluated HME against 212 industry peers in the Oil, Gas & Consumable Fuels industry. HME scores excellent points on both the profitability and health parts. This is a solid base for a good stock. HME is cheap, but on the other hand it scores bad on growth. These ratings could make HME a good candidate for value investing.
1. Profitability
1.1 Basic Checks
- HME had positive earnings in the past year.
- HME had a positive operating cash flow in the past year.
- Of the past 5 years HME 4 years were profitable.
- Each year in the past 5 years HME had a positive operating cash flow.
1.2 Ratios
- With an excellent Return On Assets value of 24.66%, HME belongs to the best of the industry, outperforming 97.64% of the companies in the same industry.
- HME's Return On Equity of 38.33% is amongst the best of the industry. HME outperforms 99.06% of its industry peers.
- HME has a better Return On Invested Capital (31.98%) than 100.00% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for HME is significantly above the industry average of 6.50%.
- The 3 year average ROIC (38.31%) for HME is well above the current ROIC(31.98%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.66% | ||
| ROE | 38.33% | ||
| ROIC | 31.98% |
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
1.3 Margins
- HME has a Profit Margin of 30.81%. This is amongst the best in the industry. HME outperforms 95.28% of its industry peers.
- In the last couple of years the Profit Margin of HME has grown nicely.
- The Operating Margin of HME (42.73%) is better than 92.92% of its industry peers.
- HME's Operating Margin has improved in the last couple of years.
- HME has a better Gross Margin (60.82%) than 79.25% of its industry peers.
- In the last couple of years the Gross Margin of HME has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 42.73% | ||
| PM (TTM) | 30.81% | ||
| GM | 60.82% |
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so HME is creating value.
- The number of shares outstanding for HME has been reduced compared to 1 year ago.
- HME has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for HME has been reduced compared to a year ago.
2.2 Solvency
- HME has an Altman-Z score of 5.05. This indicates that HME is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of HME (5.05) is better than 84.91% of its industry peers.
- The Debt to FCF ratio of HME is 0.07, which is an excellent value as it means it would take HME, only 0.07 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of HME (0.07) is better than 96.23% of its industry peers.
- A Debt/Equity ratio of 0.03 indicates that HME is not too dependend on debt financing.
- HME has a better Debt to Equity ratio (0.03) than 76.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.07 | ||
| Altman-Z | 5.05 |
ROIC/WACC3.96
WACC8.07%
2.3 Liquidity
- HME has a Current Ratio of 1.41. This is a normal value and indicates that HME is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.41, HME is in the better half of the industry, outperforming 72.64% of the companies in the same industry.
- A Quick Ratio of 1.41 indicates that HME should not have too much problems paying its short term obligations.
- HME has a Quick ratio of 1.41. This is in the better half of the industry: HME outperforms 74.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.41 | ||
| Quick Ratio | 1.41 |
3. Growth
3.1 Past
- HME shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.09%.
- Measured over the past years, HME shows a very strong growth in Earnings Per Share. The EPS has been growing by 80.04% on average per year.
- The Revenue has decreased by -0.77% in the past year.
- HME shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.97% yearly.
EPS 1Y (TTM)-9.09%
EPS 3Y72.84%
EPS 5Y80.04%
EPS Q2Q%-22.22%
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y32.32%
Revenue growth 5Y25.97%
Sales Q2Q%-13.24%
3.2 Future
- Based on estimates for the next years, HME will show a very negative growth in Earnings Per Share. The EPS will decrease by -15.87% on average per year.
- The Revenue is expected to decrease by -7.01% on average over the next years.
EPS Next Y-14.17%
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
EPS Next 5Y-15.87%
Revenue Next Year-5.82%
Revenue Next 2Y-3.77%
Revenue Next 3Y-4.28%
Revenue Next 5Y-7.01%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 7.07, the valuation of HME can be described as very cheap.
- 90.57% of the companies in the same industry are more expensive than HME, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of HME to the average of the S&P500 Index (27.67), we can say HME is valued rather cheaply.
- With a Price/Forward Earnings ratio of 7.92, the valuation of HME can be described as very cheap.
- HME's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HME is cheaper than 79.72% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 27.69. HME is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.07 | ||
| Fwd PE | 7.92 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, HME is valued cheaply inside the industry as 91.98% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, HME is valued cheaply inside the industry as 97.64% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.59 | ||
| EV/EBITDA | 3.43 |
4.3 Compensation for Growth
- The excellent profitability rating of HME may justify a higher PE ratio.
- HME's earnings are expected to decrease with -9.18% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.09
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
5. Dividend
5.1 Amount
- HME has a Yearly Dividend Yield of 4.81%, which is a nice return.
- Compared to an average industry Dividend Yield of 3.13, HME pays a bit more dividend than its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.80, HME pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.81% |
5.2 History
- HME has been paying a dividend for over 5 years, so it has already some track record.
- The dividend of HME decreased in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- 60.59% of the earnings are spent on dividend by HME. This is not a sustainable payout ratio.
DP60.59%
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
TSX-V:HME (2/12/2026, 7:00:00 PM)
2.12
-0.05 (-2.3%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-25 2025-11-25/bmo
Earnings (Next)04-15 2026-04-15/amc
Inst Owners0.71%
Inst Owner ChangeN/A
Ins Owners16.81%
Ins Owner ChangeN/A
Market Cap200.62M
Revenue(TTM)98.24M
Net Income(TTM)30.27M
Analysts84
Price Target2.6 (22.64%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.81% |
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP60.59%
Div Incr Years2
Div Non Decr Years2
Ex-Date02-12 2026-02-12 (0.025)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.91%
Min EPS beat(2)-2.91%
Max EPS beat(2)-2.91%
EPS beat(4)1
Avg EPS beat(4)-1.48%
Min EPS beat(4)-2.91%
Max EPS beat(4)2.8%
EPS beat(8)3
Avg EPS beat(8)-2.87%
EPS beat(12)5
Avg EPS beat(12)1.35%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.89%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)5.99%
Revenue beat(4)3
Avg Revenue beat(4)2.9%
Min Revenue beat(4)-0.21%
Max Revenue beat(4)5.99%
Revenue beat(8)5
Avg Revenue beat(8)0.35%
Revenue beat(12)7
Avg Revenue beat(12)-0.67%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.15%
PT rev (3m)12.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-18.18%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.51%
Revenue NQ rev (1m)1.18%
Revenue NQ rev (3m)-10.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.07 | ||
| Fwd PE | 7.92 | ||
| P/S | 2.04 | ||
| P/FCF | 4.59 | ||
| P/OCF | 3.61 | ||
| P/B | 2.54 | ||
| P/tB | 2.54 | ||
| EV/EBITDA | 3.43 |
EPS(TTM)0.3
EY14.15%
EPS(NY)0.27
Fwd EY12.63%
FCF(TTM)0.46
FCFY21.78%
OCF(TTM)0.59
OCFY27.7%
SpS1.04
BVpS0.83
TBVpS0.83
PEG (NY)N/A
PEG (5Y)0.09
Graham Number2.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.66% | ||
| ROE | 38.33% | ||
| ROCE | 42.48% | ||
| ROIC | 31.98% | ||
| ROICexc | 43.34% | ||
| ROICexgc | 43.34% | ||
| OM | 42.73% | ||
| PM (TTM) | 30.81% | ||
| GM | 60.82% | ||
| FCFM | 44.47% |
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
ROICexc(3y)41.04%
ROICexc(5y)31.02%
ROICexgc(3y)41.04%
ROICexgc(5y)31.02%
ROCE(3y)50.88%
ROCE(5y)39%
ROICexgc growth 3Y12.92%
ROICexgc growth 5Y20.01%
ROICexc growth 3Y12.92%
ROICexc growth 5Y20.01%
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.07 | ||
| Debt/EBITDA | 0.04 | ||
| Cap/Depr | 105.19% | ||
| Cap/Sales | 12.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 104.31% | ||
| Profit Quality | 144.34% | ||
| Current Ratio | 1.41 | ||
| Quick Ratio | 1.41 | ||
| Altman-Z | 5.05 |
F-Score6
WACC8.07%
ROIC/WACC3.96
Cap/Depr(3y)210.69%
Cap/Depr(5y)187.35%
Cap/Sales(3y)20.24%
Cap/Sales(5y)19.51%
Profit Quality(3y)104.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.09%
EPS 3Y72.84%
EPS 5Y80.04%
EPS Q2Q%-22.22%
EPS Next Y-14.17%
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
EPS Next 5Y-15.87%
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y32.32%
Revenue growth 5Y25.97%
Sales Q2Q%-13.24%
Revenue Next Year-5.82%
Revenue Next 2Y-3.77%
Revenue Next 3Y-4.28%
Revenue Next 5Y-7.01%
EBIT growth 1Y-3.75%
EBIT growth 3Y35.09%
EBIT growth 5Y31.88%
EBIT Next Year34.08%
EBIT Next 3Y-0.98%
EBIT Next 5Y-5.77%
FCF growth 1Y130.83%
FCF growth 3Y57.01%
FCF growth 5YN/A
OCF growth 1Y39.86%
OCF growth 3Y36.33%
OCF growth 5Y34.82%
HEMISPHERE ENERGY CORP / HME.CA FAQ
What is the ChartMill fundamental rating of HEMISPHERE ENERGY CORP (HME.CA) stock?
ChartMill assigns a fundamental rating of 7 / 10 to HME.CA.
What is the valuation status for HME stock?
ChartMill assigns a valuation rating of 8 / 10 to HEMISPHERE ENERGY CORP (HME.CA). This can be considered as Undervalued.
Can you provide the profitability details for HEMISPHERE ENERGY CORP?
HEMISPHERE ENERGY CORP (HME.CA) has a profitability rating of 9 / 10.
What is the financial health of HEMISPHERE ENERGY CORP (HME.CA) stock?
The financial health rating of HEMISPHERE ENERGY CORP (HME.CA) is 8 / 10.
Can you provide the dividend sustainability for HME stock?
The dividend rating of HEMISPHERE ENERGY CORP (HME.CA) is 5 / 10 and the dividend payout ratio is 60.59%.